C07D 241/22
Benzenesulfonamido pyrazines
C07D241/22 (Benzenesulfonamido pyrazines) appears on 27 US grants and 36 published applications in this corpus.
Search patents in C07D- Granted patents
- 27
- Published applications
- 36
- Assignees
- 22
- Inventors
- 112
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 5 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 2 | 2 |
| 2010 | 2 | 5 |
| 2011 | 0 | 3 |
| 2012 | 4 | 1 |
| 2013 | 2 | 2 |
| 2014 | 2 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 2 | 2 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 3 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient CFTR activity24 Mar 2026US 12,583,824 B2Genzyme Corporation
- Heteroaryl sulfonamides and CCR2/CCR96 Sep 2022US 11,433,061 B2ChemoCentryx, Inc.
- Heteroaryl sulfonamides and CCR2/CCR914 Jan 2020US 10,532,044 B2ChemoCentryx, Inc.
- Sulfonamide compounds and uses as TNAP inhibitors6 Aug 2019US 10,370,333 B2Sanford Burnham Prebys Medical Discovery Institute
- Neutrophil elastase inhibitor and use thereof16 Jul 2026US 2026/0200845 A1Shanghai Yidi Biotechnology Co., Ltd
- Modulators of cystic fibrosis transmembrane conductance regulator23 Nov 2023US 2023/0373939 A1Vertex Pharmaceuticals Incorporated
- Broad spectrum anti-cancer compounds12 Oct 2023US 2023/0322715 A1The Regents of the University of California
- 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity4 May 2023US 2023/0137585 A1Genzyme Corporation
- Fluoro-containing compounds, use and preparation thereof16 Jul 2020US 2020/0223839 A1Jiangsu Yingkebeita Yiyaokeji Co. Ltd
Most cited
By later US patents
- Heteroaryl sulfonamides and CCR292US 7,622,583 B2ChemoCentryx, Inc. · 2009
- Benzenesulfonamide-derivatives and their use as medicaments44US 6,667,342 B1AstraZeneca AB · 2003
- Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists30US 6,083,951 AZeneca Limited · 2000
- Heteroaryl sulfonamides and CCR2/CCR922US 8,519,135 B2ChemoCentryx, Inc. · 2013
- N-heterocyclic sulfonamides having endothelin receptor activity20US 5,668,137 AZeneca Limited · 1997